BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Jul 10, 2015; 6(7): 943-960
Published online Jul 10, 2015. doi: 10.4239/wjd.v6.i7.943
Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy
James T Pearson, Mikiyasu Shirai, Darren J Kelly, Hirotsugu Tsuchimochi, Amanda J Edgley, Mark T Waddingham
Mark T Waddingham, Amanda J Edgley, Darren J Kelly, Department of Medicine, St Vincent’s Hospital, University of Melbourne, Melbourne, Victoria 3065, Australia
Amanda J Edgley, James T Pearson, Department of Physiology, Monash University, Clayton, Victoria 3800, Australia
Hirotsugu Tsuchimochi, Mikiyasu Shirai, Department of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka 565-8565, Japan
James T Pearson, Monash Biomedical Imaging Facility, Monash University, Clayton, Victoria 3168, Australia
James T Pearson, Australian Synchrotron, Clayton, Victoria 3168, Australia
Author contributions: Waddingham MT, Edgley AJ and Pearson JT wrote the paper; all authors provided intellectual input, edited and approved the final manuscript.
Supported by The research funding from the International Synchrotron Access Program (AS/IA133) of the Australian Synchrotron (to Pearson JT); A Grant-in-Aid for Scientific Research (#E056, 26670413) from the Ministry of Education, Culture, Sports, Sciences and Technology of Japan (to Shirai M).
Correspondence to: James T Pearson, PhD, Monash Biomedical Imaging Facility, Monash University, 770 Blackburn Road, Clayton, Victoria 3168, Australia. james.pearson@monash.edu
Telephone: +61-3-99029783 +61-3-99029500
Received: August 27, 2014
Peer-review started: August 28, 2014
First decision: December 17, 2014
Revised: December 30, 2014
Accepted: March 5, 2015
Article in press: March 9, 2015
Published online: July 10, 2015
Processing time: 317 Days and 8.7 Hours
Core Tip

Core tip: Pathological changes in cardiac muscle underlie diabetic cardiomyopathy (DCM) independent of hypertension and atherosclerosis. In advanced diabetes, fibrosis, hypertrophy and apoptosis, reduce myocardial compliance, which leads to increased diastolic filling pressures and overt left ventricular diastolic dysfunction. However, detrimental changes in sarcomeric and other cytoskeletal proteins in the cardiomyocytes of animal models of diabetes precede remodeling of the cardiac extracellular matrix, which has until now been considered the main contributor to diabetic diastolic dysfunction. An important target for preventing early DCM are the protein kinase C/rho-kinase pathways that drive oxidative stress and reduce myosin head cycling and prolong Ca2+ transients.